Search
for
Sort by
Research 241–270 of 1000+
- Human epidermal neural crest stem cells as candidates for cell-based therapies, disease modeling, and drug discovery
- On the Use of Micro-Imager<sup>®</sup> to Directly Visualize Drug Distribution in Human Skin
- Human Hair in Personal Identification and Documenting Drug and Substance Abuse
- Drug-induced postinfantile giant cell hepatitis
- Expression of the L-Fucose Moiety on Infrainfundibular Follicular Keratinocytes of Terminal Follicles, Its Decreased Expression on Vellus and Indeterminate Follicles of Androgenetic Alopecia, and Re-Expression in Drug-Induced Hair Regrowth
- Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis
- The penetration efficiency of a dissolved model drug into hair follicles depends on the concentration of added nanoparticles
- Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride
- Drug safety evaluation of exemestane
- Principles and clinical applications of transcutaneous laser-assisted drug delivery: A narrative review
- Advances in structure-based drug design targeting membrane protein markers in prostate cancer
- Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a “drug dependency” and a post-finasteride “rebound effect”.
- Drug induced hair loss.
- Drug-Induced Alopecia Areata From Upadacitinib
- Drug-induced subacute cutaneous lupus erythematosus secondary to Dupilumab: A case report
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis
- Iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles accelerates drug release, decreasing their targeting effect to hair follicles
- <i>In vitro</i> and <i>in vivo</i> models for androgenetic alopecia drug development
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- Drug-Induced Hair Changes
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy
- Percutaneous Drug Delivery to the Hair Follicle
- Drug points: Remission of alopecia universalis during sulphasalazine treatment for rheumatoid arthritis
- Development and In Vitro Characterization of Neusilin® US2-Based Solid Self-Nanoemulsifying Drug Delivery System for Oral Administration of Finasteride
- The effects of androgens on drug metabolism and transport: clinical pharmacologic considerations for people assigned female at birth
- Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology
- Drug‐Free Ultrasound‐Responsive Mechanoluminescent Suture Enables On‐Demand Antibacterial Therapy and Enhanced Healing of Infected Wounds
- Mechanisms and Research Advances in Drug Delivery Systems for Psoriasis and Atopic Dermatitis